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I. INTRODUCTION 
It has been the object of this study to amplify and extend our studies on 
molecular coating of blood vessel surfaces and blood formed elements. The 
initial work on blood vessel coating in the prevention of vascular thrombosis 
has been published
1 
and our efforts have been rapidly expanded as a result of 
the John Hartford Foundation grant. The purpose of the study is to gather 
more experimental evidence on the theory of in vivo and in vitro coating of 
formed elements and vascular surfaces. At the same time, we have been devel- 
oping methods which could modify the dextran molecule and thus give us a better 
insight into the nature of the mechanism by which the molecule binds to the 
surface of the cell. Physical measurements have been undertaken to check the 
presence of the molecules on the cell surface. Methods employed thus far have 
been electron microscopy and use of the Coulter Counter. During the major part 
of this year, we have been involved in building sufficiently sensitive equip-
ment and assembling this equipment so that we may continue our use of the 
existing radioactive dextran. In the meantime, we have worked out methods 
whereby we can tag with radioactive material other dextran molecules and pos-
sibly increase the amount of radioactivity in the dextran molecule. Work has 
continued on the use of dextran in the prevention of intravascular thrombosis 
and investigators in other parts of the country have confirmed our original 
observations
2
. Our studies have been extended to include the study of throm-
bosis in the venous as well as the arterial systems and a group of patients 
with thrombophlebitis have been studied and will be reported at a later date. 
1 
II. CURRENT STATUS OF THE RESEARCH 
A. Equipment design and development  
In order to detect the levels of radioactivity expected from Carbon-14 
labeled dextran, it was necessary to develop a low level counting facility. 
These levels will be in the range from a few tens of counts per minute (CPM) 
down to a few hundredths CPM. Since conventional radiation detectors capable 
of quantative detection of the low energy radiations from Carbon-14 have back-
ground counting rates of the order of 10 - 1000 CPM, it is necessary to pro-
vide an additional means of reducing the background so that statistically 
significant determinations of the Carbon-14 levels may be made. 
A large part of the low-energy background radiation can be removed with 
adequate shielding which itself contains little or no inherent radioactivity, 
but the limiting backgrounds come from high energy cosmic rays which can only 
be removed by suitable anticoincidence shielding (i.e. surrounding the detec-
tor by other detectors which cancel out the count in the central detector if 
the external detectors indicate the radiation came from outside the shield). 
In the facility under construction, a shielded volume six inches in dia-
meter by forty-eight inches long has been provided so that several central 
Carbon-14 counters may be operated simultaneously, and also so that counters 
of various sizes may be used. This central volume is surrounded by thirteen 
N. Wood Cosmic-ray Proportional Counters used in parallel as the anticoincidence 
shield. These counters are 2" diameter x 52" long and contain P-10 (90% Ar - 
10% CH4) gas at 45 cm pressure. The active length is 48 inches. Each of the 
counters is provided with a special low-noise preamplifier and high-voltage 
decoupler and adjustment system so that the plateau of each counter can be 
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measured independently of the other counters. To minimize noise pickup and 
input capacity, these circuits are placed as close as possible to the counters 
(i.e. inside the iron shield). The outputs from the preamplifier are coupled 
together and a single cable carries the anticoincidence signal to the ring 
amplifier, a Hamner N-340 R-C - coupled linear amplifier. 
Surrounding the ring counters is an electrostatic and radiation shield 
consisting of one inch of iron and four inches of lead. 
Signals from the central Carbon-14 detectors are amplified and fed into 
a special scaler which contains an anticoincidence circuit which prevents re-
gistering a count if one or more of the ring counters has also fired at the 
same time; both the "raw" and "connected" count from the central counter are 
recorded by the scaler. This is done so that the performance of each counter 
may be constantly monitored. A block diagram of the system is shown in Fig- 
ure 1. The anticoincidence shield and preamplifier system is shown in Figure 
2. 
The electronic circuits are essentially complete and are being tested 
currently. Fabrication of the iron shield has been completed and the lead-
iron shield installed. Testing and calibration of the equipment should be 
completed by September 1. A severe delay in this part of the program occurred 
because of the delay in acceptance of the Frank H. Neely Nuclear Research Center 
where the low-level facility was to be constructed and installed. The build-
ing was to be ready for occupancy in March 1963, but actually, because of con-
struction delays, was not ready until March 1964. However, the intervening 
period was spent both in design studies and in pursuing other techniques for 
determining the mechanism of the interaction of dextran in vivo and in vitro. 
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Figure 1. Block diagram of the low level counter system. 
FRONT VIEW 
SIDE VIEW 
Figure 2. Anticoincidence shield and preamplifier system for 
low level counter system. 
B. Coulter counter studies  
If dextran is absorbed on the surfaces of the formed elements in the 
blood, it is possible that it might change the apparent size of the cells. 
This size change should be particularly apparent in the platelets where the 
effective size might double if the dextran molecules are absorbed "end on" 
in monomolecular form, as would be expected from our preliminary studies. 
It is possible also that no size change would occur since the dextran could 
conceivably replace other molecules already surface absorbed; but, in an 
attempt to study the antithrombotic mechanism, it is of interest to examine 
this possibility. 
The Coulter counter is a device that measures particle volume by mea-
suring the change in current that occurs as a particle, suspended in a 
conducting solution, passes through a small orifice with a current applied 
across the orifice. The amplitude of the current decreases in proportion to 
the volume of solution displaced by the particle. In the normal use of the 
Coulter counter, as in sizing of red blood cells clinically, the number of 
particles having amplitudes greater than a preset threshold are counted by 
adjusting the threshold to various standard incremental values. An inter-
gral size distribution can be determined; the differential size distribution 
can be obtained from this by subtraction of successive counts with increasing 
threshold. This method is somewhat time consuming and has limited statisti-
cal accuracy and resolution (i.e. usually twenty intervals are chosen giving 
twenty points on a distribution curve, red blood cells may cover only 5 to 
10 of these points). 
To increase the accuracy and resolution of the measurements and reduce 
the time required to make a measurement, an instrument, widely used in experi-
mental nuclear physics could be used in connection with the Coulter counter 
6 
detector. This instrument, the pulse height analyzer, determines the amplitude 
distribution of electronic pulses giving a record of the number of pulses hav-
ing amplitude E within dE. The particular instrument available in our laboratory 
has 400 channels, and a maximum count of 10
6 
in each channel permitting a reso-
lution of 1 part in 400 and a statistical accuracy of 0.1% maximum. 
It was of interest to apply this instrument to the dextran absorption 
problem, particularly in view of the small changes in size that might occur 
with red blood cells on absorption of dextran. However, the pulse from the 
Coulter counter differs in shape and duration from that which the pulse height 
analyzer is designed to measure. An adapter circuit, designed to convert the 
pulse into a suitable form has been built. 
The Coulter Counter Adapter Circuit (Figure 3) is an electronic means of 
interconnecting a Coulter counter and a Technical Measurements Corporation 
(TMC) Model 404 Pulse Height Analyzer (PHA) for cell size distribution analysis. 
The Coulter counter converts the passage of a cell through its aperture to a 
pulse whose amplitude is proportional to the cell volume. The rise time and 
width of this pulse is not compatible with the requirements of the TMC PHA and 
the adapter is required for proper pulse shaping. 
The TMC PHA requires an input pulse having a minimum amplitude of approxi-
mately 50 millivolts with a rise time not greater than 1 microsecond, a decay 
time of approximately 3 microseconds. The Coulter counter does not have avail-
able an output of such specifications and, therefore, some method of obtaining 
and shaping the pulse output from the Coulter counter is needed. We elected to 
sample the pulse from the Coulter counter at the plate of tube V-111, pin 6. 
This point gives a pulse having a rise time of 12 microseconds and an amplitude 
of -5 to -20 volts. The pulse is capacity coupled into the base of Q7, a 2N188 
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COULTER COUNTER ADAPTER 
Figure 3. Coulter counter adapter circuit. 
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transistor employed as an emitter follower and having a gain of 0.8. The 
emitter follower provides impedance matching between the Coulter counter and 
the relatively low input impedance of Q6, a 2N417 transistor which functions 
as the gate. The output of the emitter follower is split and fed to (1) the 
gate input and (2) an amplifier, Q5, of the grounded emitter type having a 
gain of -30. That portion of the :pulse that drives the amplifier is of suf-
ficient amplitude to drive the amplifier to saturation during the first 0.1 
microsecond of its rise. The common emitter configuration of Q5 produces a 
phase inversion of 180 ° and with saturation occurring within 0.1 microsecond 
of the start of the pulse, the output of this stage is a positive square wave 
of 8 volts amplitude and 0.1 microsecond rise time. The square wave thus ob-
tained is differentiated by the 75 picafarad coupling capacitor between Q5 
and Q1 yielding a positive and negative pulse of short duration. The 1N99 
diodes in the base circuit of Ql permit only the positive pulse to reach Ql. 
The 2N1307 transistors, Q1 and Q2, form a one shot multivibrator that 
functions as the delay circuit for the gate pulse. The pulse width of this 
circuit is made adjustable and is controlled by the Delay Adjust, a 50 kilohm 
potentiometer which can be varied between 4 and 15 microseconds. The output, 
taken from the collection of Q2, is a negative square wave, 8 volts in ampli-
tude and 4 to 15 microseconds in duration. A 250 picafarad capacitor between 
the collector of Q2 and base of Q3 differentiates the square wave yielding 
a negative and positive pulse. The positive pulse is produced by the trailing 
edge of the square wave and, therefore, occurs 4 to 15 microseconds after Ql 
was triggered (depending upon the Delay Adjust setting). The required delay 
has now been obtained and the positive pulse is used to drive the one shot 
multivibrator composed of Q3 and Q4. The duty cycle of this multivibrator is 
9 
fixed and result is a negative square wave at the collector of Q4 having an 
amplitude of 8 volts and width of 3.5 microseconds. The 3.5 microsecond square 
wave thus obtained is the gate pulse and drives the 2N417 gate (Q6). The gate 
transistor, Q6, is normally conducting and short circuits the output of Q7 
through a 2200 ohm resistor thereby preventing any output to the PHA. The 
negative gate pulse cuts off Q6 during the sampling period and a portion of 
the Coulter counter signal is passed to the output BNC connector. The sample 
of the original signal thus obtained will be 3.5 microseconds in width but 
will retain the relative amplitude information. A 1500 ohm potentiometer in 
the output of Q6 permits amplitude adjustments for driving the PHA. 
The pulse produced by the Coulter counter are essentially uniform in rise 
time regardless of amplitude. The Delay Adjust is set equal to this time and 
the sampling occurs at the peak of the input pulse. 
Cell size distributions obtained in the conventional manner, and with the 
Pulse Height Analyzer, are shown in Figure 4. From examination of these fig-
ures the increased resolution is apparent. Using this technique, a series of 
studies are under way of human red-blood-cell size distributions with and 
without dextran. Since surface absorption phenomena are rate dependent, there-
fore functions of both time and concentration, a number of measurements must be 
made under various conditions. After completion of the red-cell studies and 
the development of the technique, the more difficult measurements on platelets 
will be instituted. 
C. Electron microscopy 
In a further attempt to elucidate the nature of the intravascular surface 
phenomena, a series of studies of vascular surfaces was begun using the elec-
tron microscope. A survey of the literature revealed no work on vascular 
10 
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Figure 4. Red blood cell size distribution. 
surfaces or on preparation methods for such tissues for examination under the 
electron microscope. The electron microscopists at Georgia Tech, Mr. John 
Brown and Mr. Jim Hubbard, felt that in view of the size of the dextran mole-
cule it might be possible to see these molecules on surfaces at the high mag-
nifactions and with the new techniques available with the electron microscope. 
Since no previous studies were available, it was of interest to see what vas-
cular surfaces looked like at magnifications up to 115,000 times. Since dex-
tran is water soluble, considerable care must be taken in sample preparation 
for the studies and some new methods of preparation need to be developed. For 
the preliminary studies conventional replication was used. A staining technique 
has also been tried. 
In an attempt to see dextran on the surface of a blood vessel, two samples 
were taken of the femoral artery from a dog. The first segment was taken be-
fore dextran was given and the second, taken from the corresponding place on 
the other side of the body, was taken one hour after the admission of dextran. 
Part of both samples was split, opened out, and microtomed to give a thin sec-
tion containing the inner layer (intina) of the artery. These microtomed sec-
tions were frozen, dried in a vacuum to preserve their form, and replicated by 
the Pt shadow-carbon evaporation technique. 
The unmicrotomed pieces were stained with phosphotungstic acid and repli-
cated in wet form by a two-stage plastic-carbon replication technique. No 
differential absorption of the stain was noted upon observation of these repli-
cas in the electron microscope. 
Attempts were made to see molecular dextran by replication of slides coated 
with solutions of dextran in water and dextran in methanol and allowed to dry. 
The results of observations of these rerlicas were inconclusive. 
Future attempts to see dextran on the surface of a blood vessel will be 
made by cutting ultra-thin sections of a vessel from an "end on" orientation, 
and observing these sections directly in the electron microscope. 
Some of the resulting electron microscope photographs of vascular surfaces 
are shown in Figures 5 and 6, both with and without dextran. In these figures 
the magnification is shown as well as a scale in microns (p). For comparison, 
a red blood cell is about 8 microns in diameter and would be several times 
larger than the 115,000 times magnification photographs. Not reproduced here 
are some interesting stereoscopic photographs at high magnification. 
D. Carboxy dextran preparation 
In order to improve the tracer method and to have more Carbon-14 labeled 
dextran available for these studies, additional preparations of labeled material 
were of interest, particularly if the labeled compound could be prepared with 
higher specific activity. In addition, it was also of interest in the mechanism 
studies to alter the aldehyde groups of the dextran to see if this produces a 
change in the anti-thrombotic effect or in the duration of in vivo and in vitro  
effects. It has been proposed that the aldehyde group, being very reactive and 
on the end of the molecule, might be the active agent in the surface bonding, 
particularly in view of the preliminary tracer studies '  which indicate the 
molecules are surface bound "end on". Alteration of the end group to a carboxyl 
or an alcohol-group may change the behavior of the dextran in such a way as to 
provide a clue to the nature of the surface bonding mechanism. 
To these ends, a compound, with addition of the carboxyl group, has been 
prepared. This material has been prepared by the method of Isbell 3 . This 
method is the classical addition of the cyanide group to the aldehyde and 
a. Platinum shadowed-carbon replica of femoral artery one 
hour after the admission of dextran, (48,000x) 
b. Platinum shadowed-carbon replica of femoral artery with-
out dextran. (48,000x) 
I 	I 
c. Platinum shadowed-carbon replica of femoral artery one 
hour after the admission of dextran. (4,850x) 
d 	Platinum shadowed-carbon replica of femoral artery with- 




a. Femoral artery one hour after admission of dextran. 




b. Femoral artery without dextran. Stained with 1% phos-
photungstic acid in ethanol. (29,000x) 
0 1, 
c. Platinum shawoded-carbon replica of dextran dispersed 
in ethanol. (48,000x) 
Figure 6. 
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subsequent hydrolysis to the carboxylic acid. Carbon-14 labeled cyanide (as 
sodium cyanide) is available with high specific activity which would permit 
preparation of carboxy dextran with specific activities higher than that pre-
pared by W. L. Bloom from natural sources grown in a Carbon-14 atmosphere. 
Preparations of unlabeled carboxy dextran have been made to determine how 
the material behaves in vivo and in vitro and depending on the results of these 
studies, Carbon-14 labeled carboxy dextran will be prepared. 
Investigation of the anti--thrombotic effect in vitro with the thromboelas-
tograph with the first batch of carboxy dextran indicates that this material has 
a similar effect to dextran. Enough material for in vitro studies is currently 
being prepared. Since this material may change either the short term behavior 
or the long term persistance of the anti-thrombotic effect, a number of in vivo 
studies will be carried out in the forthcoming grant period. 
E. Electrolysis studies  
The formation of thrombi by the use of electric current has been studied 
as another means of a control situation to produce intravascular thrombosis 
and study the effects of dextran on. this thrombosis. A review of the problem 
led us to study the mechanism of electrical thrombosis. In the past it had 
been thought that this throMbosis was caused by a change in polarity of the 
transmural potentials. Our findings revealed that the electrical production 
of in vitro blood clot or in vivo thrombus was a critically voltage-dependent 
phenomenon. In analogy with the electroplating processes there exist a voltage 
below which the coagulation did not occur. Heparinized blood or plasma does 
not coagulate below a potential of 2 volts. When adequate precautions are 
taken to assure the passage of the same quantity of electricity as that which 
16 
produced clotting at a higher voltage, thrombosis was not observed. Thus the 
thrombosis appears to be a function of the voltage rather than the amount of 
current passing through the solution of blood vessel wall. Above the thres-
hold the amount of clot is a function of the number of coulombs passing through 
the medium. It was found that the potential for thrombosis was about .3 volt 
lower than the decomposition potential of isotonic saline. It is important 
that this potential is much higher than the injury potential and changes in 
transmural potentials which have been found to occur in vivo when the vessel 
wall is damaged by other means. It has thus been concluded that the initia-
tion of normal thrombotic processes cannot be pictured as modeled by the elec-
trical system which we have studied. 
The mechanism of electrical thrombosis has been used to produce a method 
with a more controllable means of producing intravascular thrombi which, al-
though not identical to the physiologic state, nevertheless provides us with 
a useful method for studying the effects of dextran or other molecules on the 
prevention of electrical thrombosis. This thrombotic model has been studied 
using dextran and it has been found that the dextran definitely diminishes the 
clot. This work has to be extended in numbers before we will be ready to re-
port on the information. As a result of this study, a contribution was volun-
tarily provided by the Glancy Foundation to study the use of this method to 
produce experimental myocardial infarction. From this investigation, a new 
method of experimental myocardial infarction has been produced and this data 
has been accepted for publication
4 . It is our intention now to use this method 
in the study with our dextran project. It is important to know whether the 
coagulation at the positive electrode is the result of pH changes of sulfhydryl 
changes in the protein molecule. This is being studied by collecting and 
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analyzing the gas that is evolved at the electrode, by studying the effects of 
non-sulfhydryl containing molecules such as gelatin, and by investigating the 
precipitation phenomenon by interposing a cellophane membrane between the elec-
trode and the plasma or blood. 
F. The hematologic (coagulation) aspects of the investigational work centering  
around dextran 
Previous studies had allowed us to document with Thrombelastography that 
the presence of dextran (especially of an average M.W. of 75,000) in the plasma 
produced a coagulation defect which is predictable on the basis of the quantity 
infused intravenously and the time elapsed following the infusion, up to eight 
days. During the past twelve months, we have continued the basic studies on 
normal human beings, patients with thrombo-embolic disease, and the mongrel 
dogs but have pointed the protocol toward more definitive methodology to better 
establish some of the hypotheses which are indicated to be fact by all reason 
but which still defy totally adequate demonstration. The problems center around 
the fact that the platelets cannot be handled for adequate study without inflict-
ing trauma which obscures the platelet characteristics which we intend to dis-
play are being modified by the physical presence of dextran. Doctor Ponder's 
electrophoretic studies and measurements of zeta potentials in 1957 suggested 
that dextran "coated" platelets. Doctor Adelson et al in 1959 used radioiso-
topic labeling techniques to further suggest that platelets were "coated" by 
dextran. No work thus far has satisfactorily proved this point nor has anyone 
been able to suggest that such a phenomenon could account for any significant 
alteration of platelet physiology such as would explain the hemorrhagic problems 
hitherto encountered following the infusion of large quantities of dextran into 
18 
patients. The use of ultra-sonic energy for "sub-lethal" platelet treatment 
before and after dextran "exposure" came to mind as a possible useful method 
for displaying the alterations in the physical properties of platelets which 
are " coated" with dextran. The main problem here was the fact that no work 
has been done with ultra-sound and platelets other than total disruption and 
subsequent study of purely chemical properties of platelets. Our work thus 
far accomplished, provides us with some most provocative data to support the 
notion that "coated" platelets are "tougher", perhaps by reason of their 
encasement, since the same quantity of ultra--sound disrupts less platelets 
and creates a different sort of morphologic change as observed with the phase 
contrast microscope. Photographic techniques have had to be developed to docu-
ment the differences observed. In order to supply a more carefully controlled 
quantity of ultra-sound, we have felt it necessary to go from the external 
"tank" application to the internal "micro-tip" application and much more back-
ground work must be continued before we begin to fully interpret the observa-
tions already made. There seems little doubt that this sort of approach will 
yield us the data which can make the heaviest inferences that platelets are 
indeed coated and that, thereby, they are ever so subtly altered to an extent 
that only their property of viscous metamorphosis is compromised. This pro-
perty can be measured only with such a method as Thrombelastography wherein 
platelets are gently handled and, following re-calcification, allowed to pro-
ceed in their chemical and physical courses of action perhaps mimicking or 
paralleling their in vivo participation in thrombus formation. 
For a long time we have been intrigued by the observation that the pre- 
sence of dextran enhances the polymerization of fibrinogen, at least as measured 
by the "thrombin time". Even without accounting for dilutional factors in some 
19 
in vitro studies, plasma plus dextran plus human thrombin clots faster than 
does plasma plus human thrombin. If dextran does form a complex fibrinogen, 
it seems that dextran-fibrin clots should either trap more of the serum pro- 
teins or less - but not the same amount as fibrin clots without dextran. Total 
nitrogen measurements of the clottable protein indicate that the presence of 
dextran does not influence the size of the clot or its "serum protein trapping" 
ability. Some refractometry studies have given us some interesting data to 
compare with those earlier made by Doctor Bloom as regards the serum protein 
dilutional effect following dextran infusions. These observations may be of 
great value later in clinical studies to govern the quantity of dextran infused 
and the interval between infusions. Some of our clinical observations thus far, 
for instance, indicate a "summation effect" when dextran infusions are spaced by 
only a few days. The alteration of the dextran molecule to have a carboxy radi-
cal on the end rather than an aldehyde has been carried out at Georgia Tech. 
Enough quantity for in vitro studies has been delivered to us for comparison 
studies with standard "aldehyde" dextran. Thrombelastographically and other-
wise, we are yet to see much difference due to the molecular alteration. 
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III. PROJECTED STUDIES FOR 1964-1965 
With an anticipated completion of the counting facilities and calibration 
by September, it will be possible to start the in vivo study of formed element 
and blood vessel surface coating. Comparison of the quantitative difference 
between damaged and undamaged surfaces will be studied. The time factors of 
duration of coating in relation to blood concentration will be done. 
It is anticipated that the Coulter Counter Studies will be completed in 
this period in regard to evaluation of this method in the problem of surface 
coating. The work has already led other workers in the biological field to re-
assess the use of the Coulter counter in all size studies. Whatever the out-
come of the surface coating studies, the new advances in instrumentation 
accomplished during last year's grant period have provided a much more accurate 
and useful method for study of particle or cell size distribution. 
The electron microscopy has not as yet revealed the presence of the dex-
tran on the blood vessel surface or, for that matter, on glass. The "end on" 
studies of blood vessels in the next grant period and the studies which have 
been initiated of alkaline metal compleKing of dextran on the cell surface 
should define the usefulness of electron microscopy in studying surface coating 
by dextran. 
Carboxy dextran will be studied in vivo and in vitro in regard to blood 
levels, urine excretion, hemostatic effects. If the characteristics of this 
molecule are sufficiently similar to dextran, a Carbon-l-- tag will be used for 
further studies. In addition, the carboxyl group will be reduced to an alco-
holic group 5 to study the effects on reactivity of the molecule. 
Electrical thrombosis is now thought to be the result of electrolysis of 
water. In the forthcoming period, the gas evolved at the electrodes during 
21 
the electrical thrombosis of plasma will be studied using a saline control. 
The study of the effects of the alterations in pH at the electrode surface 
have been initiated and preliminary findings show (as might be expected) an 
increase in H
4- 
at the positive electrode. The effects of the alterations of 
oxidation reduction potentials and the sulfhydryl group of the protein mole-
cule are planned. 
Studies on hemostasis and coagulation will be continued. The effects of 
sonic vibration on platelet stability of control and dextran treated plate-
lets will continue. The study of the coagulation mechanism in relation to the 
in vivo prevention of thrombosis will go on concomitantly with the Carbon-14 
studies in dogs. 
22 
IV. PERSONNEL 
A number of new people are participating in our project: 
1. Dr. James P. Isaacs has joined the post graduate and continuing education 
program of Piedmont Hospital as the Director of Surgical Education and Research. 
He is working actively in connection with the effect of dextran in the treat-
ment of experimental myocardial infarction. This has required working out a 
method for producing experimental myocardial infarction in animals 5 so that an 
adequate model will be available for control and experimental studies. 
2. Mr. John Lamb, biochemist and biophysicist, accompanied Dr. Isaacs to 
Piedmont Hospital from Johns Hopkins University and continues his work on elec-
trical thrombosis in connection with the Hartford Foundation grant. 
3. The personnel who have participated in this project at the Georgia Insti-
tute of Technology are Mr. R. L. Meek and Mr. Thomas Erb, Electronic Engineers 
(design of low-level counter electronics), Mrs. Dorothy DeFoor and Mr. Jim 
Kinard (Coulter counter studies), Mr. John Brown and Mr. Jim Hubbard (electron 
microscope studies), Mr. Martin Reynolds and Mr. Samuel Fowler have assisted in 
equipment construction. Dr. Robert Fetner has lent advice and assistance in 
the Coulter counter studies. Miss Paula Stevenson assisted in the early part 
of these studies. 
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During the six-month period, July 1, 1968 - December 31, 1968, a number 
of research problems were investigated. Particular emphasis was placed on 
investigating the dextran-cell surface interaction and the dextran-plasma 
(protein) interactions. These studies were directed at determining rates of 
association-disassociation, equilibrium constants and the effects of tempera-
ture both for dextran and carboxy dextran. Since there is some evidence that 
the binding sites for dextran-carboxy-dextran are similar to those for other 
weak acids, the interaction of oleic acid with plasma protein and cell surfaces 
was also studied in an attempt to more clearly define the type and number of 
binding sites available to dextran and to provide a working model to characterize 
the system. In addition Scanning Electron Microscope studies of the cell sur-
faces, with and without exposure to dextran and carboxydextran, were made to 
see if any significant alteration of the surface of red blood cells occurs 
under these conditions. 
As of July 1, 1968 the Ferst Research Laboratory of Piedmont Hospital was 
incorporated into the Nuclear and Biological Sciences Division of the Georgia 
Institute of Technology. This move provides the Ferst Laboratory with more 
ready access to the Institute facilities and conversely provides the Institute 
with access to the Medical community. It is anticipated that this joint enter-
prise will greatly enhance the interdisciplinary studies in the Biomedical and 
Bioengineering fields. 
The major problem faced during this period has been three complete turn-
overs in technical assistants for the tracer studies and the required retrain-
ing of new personnel. This turnover has slowed down the effective effort with 
a consequent delay in obtaining results. The Georgia Tech group was fortunate 
in obtaining the services of two excellent technical assistants for the summer, 
Mrs. Sue Haycock and Mr. David Schiff. The large amount of experimental data 
obtained by these two is still being analyzed and will be presented in detail 
in the final report. 
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I. TEMPERATURE DEPENDENCE OF CARBOXYDEXTRAN 
RED CELL EQUILIBRIUM CONSTANT 
In order to determine the actual equilibrium constant for the surface ad-
sorption of carboxydextran on red blood cells, the equilibrium experiments need 
to be run at constant temperature during the entire experiment. Since the basic 
information desired is the equilibrium constant at body temperature, the experi-
ment should be run at this temperature. However, with the series of manupula-
tions involved, this is difficult with the large number of samples to be pro-
cessed. By determining the equilibrium constant as a function of temperature, 
experiments at room temperature can be scaled to body temperature. In addition, 
from these data, the heat of association can be determined (red blood cell-carboxy 
dextran) and this heat (PH) is a direct measure of the bond strength of the 
carboxydextran cell surface interaction. 	The pH can then be used to compare 
with other bond strengths relatively and can also be used to compare with given 
types of interaction (i.e., hydrogen bonds, weak acid-weak base, etc.) to pro-
vide an additional clue to the nature of the surface bonding. Experiments were 
made at several initial exposure concentrations and at three temperatures. The 
temperatures were chosen on the basis of practicality for carrying out the entire 
experiment at constant temperature, and to obtain the widest range possible. 
Procedure 
The following experimental procedure was run at three different temperatures 
(5 ° C, 21 ° C, 33 ° C) with the entire experiment (except the actual counting) 
being conducted in the cold room, the laboratory, and the incubation room, 
respectively. This was done so the temperature could be maintained constant 
during the entire separations and incubation procedure. 
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Eight 1-ml samples of whole blood were obtained from a single donor. These 
were centrifuged and the red cells were washed three times with normal saline. 
The samples were then incubated with carbon-14-labeled carboxydextran for 3 
hours. (Two samples at each concentration, 2, 3, 4, and 6 grams percent). 
Each sample of red blood cells was then washed five times with 10-m1 normal 
saline, and one ml of the 5th wash was taken for counting of the supernateust. 
The remaining red cells were diluted to 10 ml with normal saline and 1-ml aliquoits 
were removed for counting. Samples were counted overnight. Blood cell counts 
(conventional RBC/mm
3
) were made on the original whole blood and on each of the 
final diluted samples. 
Results  
The amount of radioactivity bound to red blood cells of initial incubation 
solution were linear with concentration at each of the temperatures. This in-
dicates that the association is monomolecular in the carboxydextran (CD) as 
might be expected in this type of two phase equilibrium (i.e., the CD bound to 
the cells behaves as if adsorbed on a solid phase, its activity in solution is 
then unity.) The data for room temperature (21° C) were in good agreement with 
that obtained earlier at 0.5, 1, 1.5 & 2 grams percent concentration. (Note: 
in the earlier work 0.25 ml packed washed RBC were taken and 0.5-ml of suspension 
were counted giving 1/4 the activity/gm percent on the RBC samples) It is also 
interesting to note that no saturation effects were seen, even at the highest 
concentrations used (6 gm percent). 
From the slope of these activity vs concentration plots the association 
constants, K
a
, were obtained for each temperature. These results are presented 
in Table I. 
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It can be readily seen from these results that there is a strong positive 
temperature dependence in the amount of carboxydextran adsorbed on the red 
blood cells. The association constants given column one (K
a) are in terms of 
counts per minute adsorbed per sample per gram percent of carboxydextran. From 
these data, and the red blood cell count per sample the association constant shown 
in column 2 (KA) in terms of molecules of carboxydextran per red blood cell were 
obtained. The strong temperature dependence indicates a large value for the 
energy of association. One may use these data in the appropriate integrated 
form of the Van't Hoff equation*to derive the heat of association pH which is 





R VT2 1 j 
where K(T
n
) is the association constant at Tn, with Tn in absolute temperature 
units, and R is the gas law constant). From the Van't Hoff equation it can be 
seen that if K
a 
increases with temperature, then M is positive and the reaction 
is endothermic. In the units used here, pH is in kilocalories/mole. 
Having found 6H from the above equation the association constant may be 
calculated at other temperatures (i.e., 37 ° C) as is shown in the last row in 
columes 1 and 2 of Table I. 
* qq.v.: p. 829, "Textbook of Physical Chemistry," Samuel Glasstone, Van 
Nostrand, New York, (1946). 
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TABLE I 
T( ° C) 
R* 
Cal of B* 	 Method I 
Ka
(1) 	 (2) 	
Method 2 
K' from 	 kilocal/Mole 
a 
50 550 4.63 X 10
3 
5° + 21 ° +5.716 +5.842 
21 978 8.23 X 10
3 
50 + . 33 °  +5.709 +5.725 
33 1420 1.10 X 10
4 
21 ° + 33 ° +5.700 +5.554 
37 1598* 1.35 X 10
4 
Average +5.708 +5.707 
* Calculated from the vau l t Hoff equation (qq.v.: p.829, "Textbook of Physical Chemistry," 
Samuel Glasstone, Van Nostrand, New York, (1946). 
Method 1. Evaluated using six-place natural log tables. 
Method 2. Evaluated using power series expansion of In x. 
(1) In units of dpm per gm percent carboxydextran 
(2) In units of molecules of carboxydextran per red blood cell per gm percent carboxydextran. 
TABLE I 
T( ° C) 
6R 
Cal of pH* 	 Method I 	Method 2 




5 ° 550 4.63 X 10
3 
5 ° + 21° +5.716 +5; 842 
21 978 8.23 X 10
3 5 0 4. 33 0 +5.709 +5.725 
33 1420 1.10 X 10
4 
21° + 33 ° +5.700 +5.554 
37 1598* 1.35 X 10
4 
Average +5.708 +5.707 
* Calculated from the van't Hoff equation (qq.v.: p.829, "Textbook of Physical Chemistry," 
Samuel Glasstone, Van Nostrand, New York, (1946). 
Method 1. Evaluated using six-place natural log tables. 
Method 2. Evaluated using power series expansion of In x. 
(1) In units of dpm per gm percent carboxydextran 
(2) In units of molecules of carboxydextran per red blood cell per gm percent carboxydextran. 
rn 
The values of LI obtained are given in Table I. The two methods used reflect the 
sensitivity of the function to the accuracy of the calculation and is worthy of 
note because of the agreement of the averages. This also indicates that the 
relative K
a
's at different temperatures are in good agreement with each other, 
otherwise widely different values of All would have been obtained. 
The fact that the association constant increases with temperature (or 
equivalently pH is positive) is a significant datum in that it is clear evidence 
that the bonding is not hydrogen bonding. The number of molecules bound by 
hydrogen bonding decrease with increasing temperature. (K a decreases with T, 
and pH is negative). The magnitude of 6J-1 tends to indicate that a single bond, 
rather than many, per carboxydextran molecule is involved in the bonding to red 
blood cells. This is consistent with the earlier observations that carboxy-
dextran bonds more strongly than does ordinary (aldehyde) dextran and that the 
carboxyl or the (aldehyde)group respectively are responsible for the bonding 
rather than the many alcoholic groups of the molecule. From the observations 
that a stronger acid (oleic acid) can displace either dextran from cell surface, 
and these results it strongly suggests the thesis that the bonding is an acid-
protein-amine base reaction. (Note that aldehydes act as very weak acids). 
In view of the ability of both dextran and carboxydextran to prevent 
.thrombosis at damage sites in blood vessels, and the longer persistance of 
carboxydextran on surfaces, and probably on blood proteins in general, at lower 
blood levels than dextran, it is strongly indicated that carboxydextran should 
be used in treatment of thrombophlebitus and other chronic clotting problems. 
It is suggested that the anti-thrombiot:ic effect would persist longer than with 
dextran and certainly longer than with heparin and without the dangers of heparin. 
Studies should be made on the long term anti-thrombiotic effect of both dextran 
and carboxydextran. 
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II. AMOUNT OF CARBOXYDEXTRAN ATTACHED 
TO RED BLOOD CELLS 
From the data obtained in the constant temperature experiments, some 
interesting observations can be made, particularly about the amounts of carboxy-
dextran in solution and on the cell. Using the data from a sample incubated 
with 67 carboxydextran at 21 ° C as an example: 
After 5th wash: red cell count in 10 ml suspension 
= 3.82 X 10 5 RBC/mm3 
Radioactivity in 1 ml of suspension 
= 5320 dpm 
Radioactivity in 1 ml of 5th Wash 
= 920 dpm 
Hematocrit = 6 
From the hematocrit and the activity in the wash solution, it is readily de-
termined that less than 20 dpm of the activity in the RBC results from trapped 
wash in the centrifuged RBC after the 5th wash. Neglecting this small amount, 
the activity adhering to the Red Blood Cells is (per cell) 





Since the specific activity of the carboxydextran is 1-me/gm, this cor-
responds to 0.627 X 10
-14 
gm of dextran/RBC. The average molecular weight is 
75,000, therefore this weight corresponds to 5.03 X 10
4 molecules of carboxy-
dextran per red blood cell. Comparison to the original amount of carboxydextran 
shows that 0.004% has adhered to the red blood cells after five 10-m1 saline washes. 
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III. PROCEDURE STUDIES: RED BLOOD CELL-DEXTRAN EQUILIBRIUM EXPERIMENTS 
In the sample preparation of mixtures containing red blood cells and/or 
plasma protein it is necessary to solubilize the cells and/or protein before 
counting in the liquid scintillator mixture: the color from the hemoglobin 
must be removed or the light from the scintillations will be highly absorbed 
resulting in too much quench. Frequently, it was observed.that an abnormally 
large variation occurred in the observed tracer counts with successive dupli-
cate runs. These variations were believed to be in excess of the combined 
experimental errors due to pipeting, volume of cell measurements, counting 
statistics, etc. Several studies were made to determine if this was due to 
the incomplete solution of the cell protein. It was found that twice as much 
solubilizer was needed as had been recommended by the manufacturer (Nuclear-
Chicago). This decreased the count-efficiency variation with time but did not 
eliminate it. The following series of procedures was then tried to determine 
a standard procedure. 
In each case one-ml samples of whole blood were taken, the red blood cells 
washed three times with normal saline, the cells separated each time by centri-
fugation. The cells were then incubated with carbon-14 labeled carboxy-dextran 
for three hours and washed five times with normal saline. The cells were resus-
pended in 10 ml of normal saline and one-ml aliquots of the suspension were 
processed by the following methods: 
Procedure I  
To one-ml of the red blood cell suspension in a standard sampling vial was 
added 3-drops of 507. H202 at 5 minute intervals. The suspension was allowed to 
stand 20 minutes to decolorize. Two-ml of NCS were then added and the solution 
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allowed to stand for 90 minutes to solubilize. Fifteen-ml of tolulene based 
scintillator was then added and the solution counted after 2-minute dark 
adaption. 
Procedure II  
To one-ml of the red blood cell suspension was added 2-ml of NCS and the solu-
tion was allowed to stand 15 minutes. Five drops of 50% H 202 were added and 
allowed to stand for 90 minutes after which 15-ml of the toluene scintillator 
were added and the solution counted. 
Procedure III  
Two-ml NCS was placed in the counting vial and 5 drops of 50% H 20 2 
were added. 
One ml of the red cell suspension was then added and allowed to stand 90 minutes. 
The sample was then counted. 
The most often encountered problem in liquid scintillation counting, chemi-
or photo- luminescence did not seem to be the cause of the variations on investi-
gation. Dark adaption for 2 minutes before counting was sufficient to remove 
the photo-luminescence, and chemical reactions producing light in the scintil-
lation mixture were not significant. However, it was observed that the count 
rate did vary as a function of time after preparation as evidenced by the quench 
ratio and the observed net counting rate. One of the primary causes of this 
variation was the amount of solubilizer (NCS) added. It was observed that, when 
counting red blood cells, variations in the corrected disintegrations-per-minute 
(dpm) of 30% could occur over a period of time (13 hours). This was not observed 
for samples not containing red blood cells (washes, etc.). 
Each sample was counted several times in succession; immediately after 
--pieparation, and at intervals up to 13 hours. 
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It was found that Procedure I gave satisfactory, unchanging efficiency 
corrections after two hours whereas the others were still changing after 





) and the toluene are critical to the more rapid stabilization of the 
counting efficiency. In fact, it is recommended that the samples be prepared 
by Procedure I and allowed to stand overnight (approximately 12 hours) before 
counting to ensure stabilization. It appears that the culprit in the changing 
efficiency is the oxygen evolved from the reaction of the hydrogen peroxide 
with the biological material. The waiting period after addition of the H 202 
 to allow the excess oxygen to evolve seems to solve the problem completely. 
Addition of the peroxide after the NCS requires more peroxide to decolorize 
due to the raction of some of the peroxide with the NCS. 
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IV. FAT BINDING TO PROTEIN AND PROTEIN SURFACES 
Studies were continued in this period on the interaction of fatty acids with 
proteins. 	Most of the effort was devoted to investigating the equilibrium of 
fatty acids with plasma protein. A clinical procedure is being developed for 
determining the relative additional fatty acid that can be bound by plasma pro-
tein. The "nearness-to-saturation" appears to differ from individual to indivi-
dual, and may be indicative of the tendency of fatty deposits in blood vessels 
and other diseases. The procedures reported earlier were investigated further, 
particularly the use of ion-exchange resins to remove unbound fatty acid from 
plasma-fatty acid mixtures. The intent of this procedure is to separate un-
bound fatty acid from solutions containing plasma and fatty acid in order to 
determine the amount of fatty acid bound to plasma protein. After exposure of 
plasma to fatty acid, an ion exchange resin is added, the mixture agitated and in-
cubated for various times, and the resin is allowed to settle. The solution then 
contains essentially only protein bound fatty acid. By using radioactively 
labeled fatty acid, the amounts bound to resin or to protein can be determined. 
The primary problem investigated was whether the addition of the resin 
significantly changed the amount of fatty acid bound to the protein: 
In the original reaction, 
Fatty acid + protein .7-2 protein-bound fatty acid 
FA + P FAP 
The resin-fatty acid interaction 
R + FA7:-. FA-R 
The overall reaction with both present: 




If the bonding to protein is much stronger than to resin, and if the rate of 
dissociation of protein-bound fatty acid is slow, and the rate of association 
with the resin is fast, then adding the resin will not cause a significant shift 
in the protein-fatty acid equilibrium. 
The resins studied were Amberlite, Dowex, and Rexyn. The reaction rates 
with aleic acid were slowest with Amberlite, next slowest withDowex, and 
fastest with Rexyn. The amounts bound per unit weight were largest with Dowex, 
and least with Amberlite. 
These results are applicable to the procedure for determining the number 
of acid binding sites both on plasma protein and on red blood cells. It is of 
interest to determine the number of binding sites and their relative strength of 
'bonding in this manner to compare with the number of sites available for dextran 
bonding. These studies are continuing and the details will be given in the final 
report. A large body of data has been collected and is being evaluated currently. 
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V. SCANNING ELECTRON MICROSCOPE STUDIES 
With the advent of the Scanning Electron Microscope which allows visual-
ization of surfaces and surface contours at high magnification, it was of in-
terest to see if the cell surface interaction phenomena could be seen in any 
manner. The electron microscope group at Georgia Tech, directed by Mr. John 
L. Brown, Senior Research Physicist, has recently obtained a Phillips Scanning 
Electron Microscope, Model EM-200, with a maximum resolution of 7 Angstroms 
and maximum practical magnification of 2 x 10 6 X. This is an addition to the 
several conventional transmission-type electron microscopes which had been 
used earlier in the dextran studies (see Annual Progress Report 1966). The 
scanning electron microscope has the ability to give a representation, on film, 
of objects over a wide range of magnification that is essentially the same as 
would be seen by conventional photography of macroscopic objects; that is, al-
though two-dimensional in nature, the third dimension is indicated by shadow-
like effects, in contrast to the conventional transmission only pictures. 
Since the surface and surface contours are visualized in this manner, it was 
felt that perhaps the effects of the surface absorption of macro-molecules, 
particularly dextran and carboxy-dextran, could be observed on the red blood 
cell itself, which could be used as a prototype for the cell-surface coating 
studies. It was also possible that an extremely long molecule, such as dex-
tran, if arranged in a regular manner on the cell surface, could be seen either 
as producing an apparent cell size increase, or by masking the finer detail of 
the surface. It was also suggested that some distortion or change of the cell 
shape might result from this macro-molecular coating. 
As is always the case with electron-microscope sample preparation, great 
care must be taken to avoid introduction of artifact by sample handling and 
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and preparation. This is particularly true when one is dealing with cells, 
especially those as fragile and distortable as red blood cells. In addition, 
it should also be noted that a "training phase" is necessary in such a study 
in that one must learn the correlation of what one "sees" with an electron 
micrograph with what one has learned to see in conventional optical microscopy. 
In an attempt to avoid some of these pitfalls, Miss Jean Clark, hemotology 
technologist, prepared all the samples for electron microscopy and at the same 
time observed parallel samples with the more familiar optical techniques. The 
transmission-type electron microscope was also used with similar samples. This 
technique was very fruitful in detecting the introduction of artifact during 
sample preparation. These results are described below. Several sample prep-
. 
aration techniques were tried and from our experience it is obvious that con- 
siderably more extensive research is needed in this area when dealing with cells 
such as red blood cells. 
Procedures:  
Sample Preparation - Red Blood Cells for Scanning Electron Microscopy 
In view of the large number of variations in sample preparations 
tried, a summary listing of the samples is given below. In each case fresh, 
whole human blood samples were taken, and if applicable, centrifuged and washed 
three times with normal saline. Some samples were made with whole blood. Sam-
ples were incubated with dextran in saline, in sucrose, saline alone, both with 
and without anti-coagulation agents such as EDTA or citrate, etc. Various 
freeze-drying techniques were tried and various shadowing techniques and ma-
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from above 3 
4 CITRATE whole blood 	X 




6 NONE 	No cells 	 X 
	
X 
7 CITRATE Plasma 
8 CITRATE 
Samples Studied With 
Scanning Electron Microscope 
Exposed to 
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3CITRATE 	platelet rich 
plasma 
4 	
no c all s 
Incubated 
Samples Studied with 
Transmission Electron Microscope 
Conclusions: 
In spite of the large number of techniques tried, no clear correlation of 
surface appearance with the presence or absence of dextran could be obtained. 
In fact, two effects were seen to predominate in the appearance of the samples, 
both having to do with sample preparation. The manner of washing of the red 
blood cells and the incubation time have a major effect on'the cell appearance. 
Also the method used for removing the water surrounding the cells prior to in-
serting the samples into the high vacuum necessary for electron microscopy, has 
a major effect on the cell appearance. Since the cells, while in solution, must 
have nearly the correct, normal saline concentration to avoid hemolysis, then 
during evaporation of the water the saline concentration must increase to satur-
ation, causing some cell damage (frequently rupture). In any case, the hydro-
scopicity of sodium cloride tends to remove water from the cell itself, causing 
apparent changes. This is also the disadvantage of freeze drying. If after 
any of the water removal techniques, the cells are exposed to humidity, then 
the small amount of water adsorbed will create a concentrated saline solution 
at or near the cell surface causing some distortion. These two problems are 
difficult to overcome and more study is needed in this area. On reviewing the 
entire series of photographs taken, the overall impression is that exposure to 
dextran tends to preserve the appearance of the red blood cell. It is of in-
terest to note however that, in spite of all the difficulties, several tech-
niques were developed which look promising for the visualization of red blood 
cells and even platelets at very high magnification. Sample photographs are 
shown in the Appendix of red blood cells at various magnifications. A consid-
erable amount of detail can be seen in these photographs. However, some more 
extensive study is needed to determine which are due to artifact and which are 
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due related to the real surface appearance. As is always the case, what one 
would really like to know is the appearance of the cell in vivo rather that in 
vitro, particularly when the cell has been multiply processed and studied in 
the absence of any surrounding fluid. In conclusion, although unable to clear-
ly determine the surface effects of dextran or being able to visualize dextran 
on the surface of the cell, the scanning electron microscope shows great prom-
ise for this purpose. Considerable study is needed in sample preparation. 
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FIGURE 1. WHOLE BLOOD with CITRATE ANTICOAGULANT - INCUBATED at 37 ° 
 for 30 minutes - MAGNIFICATION 9360X 
FIGURE 2. WHOLE CITRATED BLOOD - 0.9 ml INCUBATED with 0.1 ml 6% 
DEXTRAN (MW 75,000) in SALINE for 30 minutes at 37 ° C -
MAGNIFICATION 10,274X 
FIGURE 3. SALINE WASHED RED BLOOD CELLS - INCUBATED 2.5 hrs at 37 ° C 
with 1 m1 6% DEXTRAN (MW 75,000) in SALINE 
FIGURE 4. WHOLE CITRATED BLOOD - 0.8 ml with 0.2 ml NORMAL SALINE -
TRANSMISSION ELECTRON MICROGRAPH - MAGNIFICATION 12,800X 
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FIGURE 5. WHOLE CITRATED BLOOD -- RED BLOOD CELL SURFACE in FIG. 4 
MAGNIFICATION 192,000X 
FIGURE 6. WHOLE CITRATED BLOOD - 0.8 ml with 0.2 m1 6% DEXTRAN in 
SALINE. TRANSMISSION ELECTRON MICROGRAPH MAGNIFICATION 
12,800X 
FIGURE 7. WHOLE CITRATED BLOOD - CLOSE-UP of CELL SURFACE in FIG. 6. 
FIGURE 8. WHOLE CITRATED BLOOD RED BLOOD CELL SURFACE - 0.8 ml with 
0.2 ml 6% DEXTRAN in DEXTROSE - TRANSMISSION ELECTRON 
MICROGRAPH - MAGNIFICATION 192,000X 
